Cipta Sarana Medika Tbk. vs Nippon Indosari Corpindo Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Nippon Indosari Corpindo Tbk. trades at Rp605 (market cap 3.77T, 183.8K 24h volume). The key difference: Nippon Indosari Corpindo Tbk. is far larger — about 23.8× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 183.8K). Which is the better fit depends on your goals.
| DKHH | ROTI | |
|---|---|---|
Market Cap | 158.12B | 3.77T |
Volume | 8.21M | 183.8K |
Lot | 82.15K | 1.84K |
Turnover | 515.2M | 111.59M |
Average Price | 62.72 | 607.13 |
Value | 515.2M | 111.59M |
Indicative Equilibrium Price | 63 | 605 |
Indicative Equilibrium Volume | 1.33K | 330 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Nippon Indosari Corpindo (the company) was established under its original name of PT Nippon Indosari Corporation base on notarial deed No.11 of Benny Kristianto, S.H, dated on Mar 8, 1995. The Companys articles of association has been amended several times, most recently by notarial deed No. 71 of Isbandi, S.H., dated Feb 24, 2010, concerning among others, the change in the Company’s name, and public offering.
Read more on ROTI →